SEC Form 4 · accession 0001683168-19-000148
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kazuko Matsuda
Officer — Chief Medical Officer
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $7.00 | Jan 15, 2019 | A | 295,000 | A | Jan 15, 2019 | Jan 5, 2028 | Common Stock | 295,000 | 295,000 | D |
Explanation of responses
- F1On January 6, 2018, the reporting person was granted an option to purchase 295,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option.